ORMAT TECHNOLOGIES, INC. 8-K

What Happened

• Ormat Technologies, Inc. announced it completed a previously announced private offering of $1.0 billion aggregate principal amount of convertible senior notes on March 20, 2026. The offering consists of $825 million of 1.50% Series A Convertible Senior Notes due 2031 and $175 million of 0.00% Series B Convertible Senior Notes due 2031 (amounts reflect full exercise of initial purchaser options). The Series A and Series B Notes were issued under separate indentures dated March 20, 2026. Each series matures on March 15, 2031, unless earlier converted, redeemed or repurchased.

Key Details

• Offering size and terms: $1.0 billion total (Series A $825M at 1.50% interest; Series B $175M at 0.00% with any special interest per the indenture). Indentures dated March 20, 2026; maturity March 15, 2031.
• Conversion mechanics: Initial conversion rate of 7.1225 shares of common stock per $1,000 principal (≈ $140.40 conversion price per share). Conversions can be settled in cash up to the principal amount and then in cash, shares, or a combination at the company’s election for any remainder.
• Use of proceeds and repurchases: Net proceeds estimated ≈ $975.7 million. The company used ≈ $287.9M of proceeds plus $25M cash and issued ≈ 0.6M shares to repurchase ≈ $285.9M principal of its 2.50% Convertible Senior Notes due 2027; used ≈ $25M of proceeds to repurchase common stock at $108.00 per share. After settlement, 2027 Notes outstanding expected to be ≈ $190.6M.
• Conversion and redemption windows: Notes are generally convertible only under specified conditions until Nov 15, 2030 (after which they are freely convertible until shortly before maturity). Company cannot redeem before March 20, 2029; may redeem after that subject to stock-price conditions.

Why It Matters

• Capital structure: The transaction raises near‑term liquidity (~$975.7M net) while adding $1.0B of senior unsecured convertible debt that is equal to other unsecured obligations and junior to any secured debt. This changes the company’s debt profile and extends financing to 2031.
• Dilution and offset actions: The notes are convertible into common stock at a ~ $140.40-equivalent price, which creates potential future dilution. Management used a portion of the proceeds plus shares to repurchase 2027 convertible notes and repurchased shares to help offset some dilution from earlier convertibles.
• Investor considerations: Retail investors should note the interest profile (Series A pays 1.50% semiannually; Series B has no regular interest), the conversion price and conversion limitations through 2030, the optional repurchase right for Series B in March 2027, and conditions under which the company may redeem the notes. These features affect future dilution risk, cash interest obligations, and seniority in a default.